Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model

Kazuaki Taguchi, Toru Maruyama, Yasunori Iwao, Hiromi Sakai, Koichi Kobayashi, Hirohisa Horinouchi, Eishun Tsuchida, Toshiya Kai, Masaki Otagiri

研究成果: Article

29 引用 (Scopus)

抄録

Hemoglobin-vesicles (HbV) are liposomal artificial oxygen carriers that may be useful as a resuscitation fluid during hemorrhagic shock (HS). It is well-known that the pharmacokinetic properties of liposome change in response to both pathological conditions and repeated administration. Therefore, we compared the pharmacokinetics of single versus repeated administration of HbV during HS. HS was induced by withdrawal of 40% of total blood volume. The normal (non-HS) and HS1 group was received an injection of 125I-labeled HbV (125I-HbV). The HS2 group was resuscitated with non-labeled HbV, and 1 h later, it received an injection of 125I-HbV. The half-life was shorter in HS1 rats, but it returned to non-HS levels after the second HbV injection. During 12 h after administration of HbV, tissue distribution of HbV was greatest in the HS1 group; however, the HS2 group had the greatest tissue distribution at subsequent time points. Excretion into urine, major elimination pathway, did not differ between non-HS and HS1 rats, but was significantly reduced in the HS2 group. Furthermore, the half-life of HbV in humans was estimated to be approximately 3-4 days using an allometric equation. This suggests that HbV may be a useful artificial oxygen carrier in HS based on HbV pharmacokinetics.

元の言語English
ページ(範囲)232-239
ページ数8
ジャーナルJournal of Controlled Release
136
発行部数3
DOI
出版物ステータスPublished - 2009 6 19
外部発表Yes

Fingerprint

Hemorrhagic Shock
Hemoglobins
Pharmacokinetics
Injections
Shock
Tissue Distribution
Half-Life
Oxygen
Blood Volume
Resuscitation
Liposomes
Urine

ASJC Scopus subject areas

  • Pharmaceutical Science

これを引用

Taguchi, K., Maruyama, T., Iwao, Y., Sakai, H., Kobayashi, K., Horinouchi, H., ... Otagiri, M. (2009). Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model. Journal of Controlled Release, 136(3), 232-239. https://doi.org/10.1016/j.jconrel.2009.02.009

Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model. / Taguchi, Kazuaki; Maruyama, Toru; Iwao, Yasunori; Sakai, Hiromi; Kobayashi, Koichi; Horinouchi, Hirohisa; Tsuchida, Eishun; Kai, Toshiya; Otagiri, Masaki.

:: Journal of Controlled Release, 巻 136, 番号 3, 19.06.2009, p. 232-239.

研究成果: Article

Taguchi, K, Maruyama, T, Iwao, Y, Sakai, H, Kobayashi, K, Horinouchi, H, Tsuchida, E, Kai, T & Otagiri, M 2009, 'Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model', Journal of Controlled Release, 巻. 136, 番号 3, pp. 232-239. https://doi.org/10.1016/j.jconrel.2009.02.009
Taguchi, Kazuaki ; Maruyama, Toru ; Iwao, Yasunori ; Sakai, Hiromi ; Kobayashi, Koichi ; Horinouchi, Hirohisa ; Tsuchida, Eishun ; Kai, Toshiya ; Otagiri, Masaki. / Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model. :: Journal of Controlled Release. 2009 ; 巻 136, 番号 3. pp. 232-239.
@article{7fca0ce0b8364c1290501df36c7665a0,
title = "Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model",
abstract = "Hemoglobin-vesicles (HbV) are liposomal artificial oxygen carriers that may be useful as a resuscitation fluid during hemorrhagic shock (HS). It is well-known that the pharmacokinetic properties of liposome change in response to both pathological conditions and repeated administration. Therefore, we compared the pharmacokinetics of single versus repeated administration of HbV during HS. HS was induced by withdrawal of 40{\%} of total blood volume. The normal (non-HS) and HS1 group was received an injection of 125I-labeled HbV (125I-HbV). The HS2 group was resuscitated with non-labeled HbV, and 1 h later, it received an injection of 125I-HbV. The half-life was shorter in HS1 rats, but it returned to non-HS levels after the second HbV injection. During 12 h after administration of HbV, tissue distribution of HbV was greatest in the HS1 group; however, the HS2 group had the greatest tissue distribution at subsequent time points. Excretion into urine, major elimination pathway, did not differ between non-HS and HS1 rats, but was significantly reduced in the HS2 group. Furthermore, the half-life of HbV in humans was estimated to be approximately 3-4 days using an allometric equation. This suggests that HbV may be a useful artificial oxygen carrier in HS based on HbV pharmacokinetics.",
keywords = "Accelerated blood clearance (ABC) phenomenon, Extrapolation, Hemorrhagic shock, Liposome, Oxygen carrier",
author = "Kazuaki Taguchi and Toru Maruyama and Yasunori Iwao and Hiromi Sakai and Koichi Kobayashi and Hirohisa Horinouchi and Eishun Tsuchida and Toshiya Kai and Masaki Otagiri",
year = "2009",
month = "6",
day = "19",
doi = "10.1016/j.jconrel.2009.02.009",
language = "English",
volume = "136",
pages = "232--239",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model

AU - Taguchi, Kazuaki

AU - Maruyama, Toru

AU - Iwao, Yasunori

AU - Sakai, Hiromi

AU - Kobayashi, Koichi

AU - Horinouchi, Hirohisa

AU - Tsuchida, Eishun

AU - Kai, Toshiya

AU - Otagiri, Masaki

PY - 2009/6/19

Y1 - 2009/6/19

N2 - Hemoglobin-vesicles (HbV) are liposomal artificial oxygen carriers that may be useful as a resuscitation fluid during hemorrhagic shock (HS). It is well-known that the pharmacokinetic properties of liposome change in response to both pathological conditions and repeated administration. Therefore, we compared the pharmacokinetics of single versus repeated administration of HbV during HS. HS was induced by withdrawal of 40% of total blood volume. The normal (non-HS) and HS1 group was received an injection of 125I-labeled HbV (125I-HbV). The HS2 group was resuscitated with non-labeled HbV, and 1 h later, it received an injection of 125I-HbV. The half-life was shorter in HS1 rats, but it returned to non-HS levels after the second HbV injection. During 12 h after administration of HbV, tissue distribution of HbV was greatest in the HS1 group; however, the HS2 group had the greatest tissue distribution at subsequent time points. Excretion into urine, major elimination pathway, did not differ between non-HS and HS1 rats, but was significantly reduced in the HS2 group. Furthermore, the half-life of HbV in humans was estimated to be approximately 3-4 days using an allometric equation. This suggests that HbV may be a useful artificial oxygen carrier in HS based on HbV pharmacokinetics.

AB - Hemoglobin-vesicles (HbV) are liposomal artificial oxygen carriers that may be useful as a resuscitation fluid during hemorrhagic shock (HS). It is well-known that the pharmacokinetic properties of liposome change in response to both pathological conditions and repeated administration. Therefore, we compared the pharmacokinetics of single versus repeated administration of HbV during HS. HS was induced by withdrawal of 40% of total blood volume. The normal (non-HS) and HS1 group was received an injection of 125I-labeled HbV (125I-HbV). The HS2 group was resuscitated with non-labeled HbV, and 1 h later, it received an injection of 125I-HbV. The half-life was shorter in HS1 rats, but it returned to non-HS levels after the second HbV injection. During 12 h after administration of HbV, tissue distribution of HbV was greatest in the HS1 group; however, the HS2 group had the greatest tissue distribution at subsequent time points. Excretion into urine, major elimination pathway, did not differ between non-HS and HS1 rats, but was significantly reduced in the HS2 group. Furthermore, the half-life of HbV in humans was estimated to be approximately 3-4 days using an allometric equation. This suggests that HbV may be a useful artificial oxygen carrier in HS based on HbV pharmacokinetics.

KW - Accelerated blood clearance (ABC) phenomenon

KW - Extrapolation

KW - Hemorrhagic shock

KW - Liposome

KW - Oxygen carrier

UR - http://www.scopus.com/inward/record.url?scp=67349215150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349215150&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2009.02.009

DO - 10.1016/j.jconrel.2009.02.009

M3 - Article

C2 - 19245823

AN - SCOPUS:67349215150

VL - 136

SP - 232

EP - 239

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -